
DMed
缔脉生物
DMed
Biotech/Healthcare
ClinChoice (Dimai Biomedical Technology (Shanghai) Co., Ltd.) is a clinical contract research organization (CRO) based in China with a global outlook. Many of its employees are industry elites from multinational pharmaceutical companies and authoritative experts from Chinese and US drug regulatory…
Latest round: Series C Extension (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.